PPT-Unique botanically-based pharmaceutical solutions

CORPORATE PRESENTATION Pharmaceuticals Q4 2017 This presentation contains forwardlooking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 For this purpose any statements contained herein or which are otherwise made by or on behalf of the Company that are not statements of historical facts may be deemed forwardlooking statements Without limiting the generality of the foregoing words such as may will to plan expect believe anticipate intend could should would estimate or continue or the negative or other variations thereof or comparable terminology are intended to identify forwardlooking statements Shareholders are cautioned that all forwardlooking statements involve risk and uncertainties which may cause results to differ materially from those set forth in the statements Such risks and uncertainties include but are not limited to the following the success of research and development activities and the speed with which regulatory authorizations and product launches may be achieved government regulation generally competitive developments the ability to successfully market products domestically and internationally difficulties or delays in manufacturing or issues relating to manufacturing capacity commercial obstacles to the successful introduction of brand products generally legal defense costs insurance expenses settlement costs and the risk of an adverse decision or settlement relating to product liability patent protection governmental investigations and other legal proceedings the Companys ability to acquire and protect patents and other intellectual property both domestically and internationally the absence of certainty regarding the receipt of required regulatory approval or the timing or terms of such approvals any changes in business political and economic conditions business interruption due to hurricanes or other events outside of the Companys control. Kim Devlin FBDO [. Hons. ] CL. Contact lens solutions. Core competencies for Optometrists, CLO and Dispensing Opticians all state the same thing.. To be competent we all have to understand the care of all types of CLs, the only difference is the detail . Matravers. Vice President Product Development. The Difference is. Pure, Safe, Beneficial. ™. Our Brand. a . premium brand with a Swiss heritage. . products . that are healthy, botanically based, . . BY. Dr. RAJESH KUMAR SINGH. Associate Professor. Delhi Technological University (DCE), Delhi. . 1. Plan of Presentation. Introduction of Pharmaceutical Industry. March 27th 2014, University of Zurich . Fabienne Heimgartner, Interpharma. What. . it. . needs. . for. . one. . drug. CHF . investment. working. . hours. . experiments. scientists. drug. 1 000 000 000. Solutions. In pharmaceutical terms, solutions are “liquid preparations that contain one or more chemical substances dissolved in a suitable solvent or mixture of mutually miscible solvents” ( aqueous or non –aqueous) .. . . Presented by. Ma . Shiao. Lin. MBA IV ,59 . . A Prescription for Saving$. . What is the Statewide Pharmaceutical Program (SPP)?. Administered by the California Department of General Services (DGS), Pharmaceutical Acquisitions Section. Created by Government . Pada Lee, Joanna Bomba, Andrew Angeles. Where we began. Using Web-based Solutions to End Veteran Homelessness in Los Angeles. Pada Lee, Joanna Bomba, Andrew Angeles. Using Web-based Solutions to End Veteran Homelessness in Los Angeles. Eleni MANOLI. European Commission. Directorate General for Research and Innovation. e-mail: eleni.manoli@ec.europa.eu. The challenge. Floods in Copenhagen, Denmark. Storm tide in . Bremenhaven. , Germany 2013-12-06, wikipedia.org. TOWAHARMACEUTICAL CO.,LTD.reaches an agreementwith ESTEVE to acquire ESTEVE’s genericdivision, PensaInvestmentsThe operation will accelerate TOWA’s a companyspecializing in generic drugs a The GEM Group is a leading manufacturer of valves measurement and control systems employing over 1700 members of staff worldwide With six manufacturing sites and 26 subsidiaries as well as a large net Stage three . Solutions. are liquid pharmaceutical preparation contain one or more chemical substance dissolved in one or more suitable solvent to produce single phase system . Standard solution . Types of solutions . official solutions. Stage: 3/ 1st course. Dr. Ameer S. Sahib. Define. . Official solutions are liquid preparations that contain one or more chemical substances dissolved in liquid solvent, and are mentioned in one of pharmacopeia i.e., USP, BP, NF. For example, Iodine solution (NF).. Expectations from European industry . regarding . collaboration on drug quality and environment. A Global industry acts with global standards. 2. Excellence Builds on Continual Improvement. 3. EFPIA .